Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S303100
Reexamination Certificate
active
11433848
ABSTRACT:
Compounds of Formula (I) and (II) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
REFERENCES:
patent: 3340269 (1967-09-01), Blatter
patent: 3365459 (1968-01-01), Blatter
patent: WO 9501980 (1994-06-01), None
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley % Sons, 1995, pp. 975-977.
Banker (Modern Pharmaceutics) Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
Barth, F., et al.,Current Medicinal Chemistry, “The Development of Cannabinoid Antagonists”, vol. 6, pp. 748-755 (1999).
Duplantier, A., et al.,J. Med Chem. “7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as Novel Inhibitors of Human Eosinophil Phosphodiesterase”, vol. 41, pp. 2268-2277 (1998).
Muccioli, et al.,Current Medicinal Chemistry, “Current Knowledge on the Antagonists and Inverse Agonists of Cannabinoid Receptors”, vol. 12, pp. 1361-1394 (2005).
Smith, et al.,IDRUGS, “Recent Advances In the Research and Development of CB1 Antagonists”, vol. 8(1) pp. 53-66 (2005).
Carpino Philip A.
Dow Robert L.
Benson Gregg C.
Musser Arlene K.
Owens Amelia A.
Pfizer Inc.
LandOfFree
Cannabinoid receptor ligands and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cannabinoid receptor ligands and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cannabinoid receptor ligands and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3725636